Restorative neurology in movement disorders

Peter Hagell

Research output: Contribution to journalArticlepeer-review

4 Citations (SciVal)


Cell replacement for restoration of neurological functions in patients with movement disorders has been investigated for more than 15 years. Initial attempts used autologous adrenal medulla grafts implanted into the denervated striatum of patients with Parkinson's disease (PD). This approach was soon abandoned in favor of intrastriatal implantation of human embryonic mesencephalic tissue, rich in dopaminergic neurons. Available data from grafted PD patients show long-term (up to 10 years) graft survival and clinical benefits. The pattern and magnitude of symptomatic relief following transplantation, however, are incomplete and the outcome varies among patients. The need for large amounts of human embryonic tissue has to be circumvented and a better understanding of the relationship between graft placement and symptomatic recovery is necessary before this procedure can be offered to larger groups of patients. Clinical trials in Huntington's disease have so far shown inconclusive results. Neural cell replacement therapy is still an experimental procedure, but has the potential to become a future restorative treatment in PD and other movement disorders.
Original languageEnglish
Pages (from-to)256
JournalJournal of Neuroscience Nursing
Issue number5
Publication statusPublished - 2000

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Caring Sciences (Closed 2012) (016514020)

Subject classification (UKÄ)

  • Nursing


Dive into the research topics of 'Restorative neurology in movement disorders'. Together they form a unique fingerprint.

Cite this